Loading...
•
Sep 30, 2021
Seer Q3 2021 Earnings Report
Seer's third quarter results for 2021 showed revenue growth driven by product sales and services, but also increased operating expenses leading to a higher net loss compared to the previous year.
Key Takeaways
Seer, Inc. reported revenue of $2.2 million for the third quarter of 2021, a significant increase from $72 thousand in the same period of 2020. This growth was primarily driven by sales of products related to the Proteograph Product Suite and services performed for a large pharmaceutical company. However, the company's operating expenses also increased substantially, leading to a net loss of $18.4 million, compared to a net loss of $8.2 million in the prior year period.
Revenue increased to $2.2 million, up from $72 thousand year-over-year.
Product-related revenue reached $1.6 million, including $787 thousand from related parties.
Gross profit was $1.2 million with a gross margin of 54%.
Net loss increased to $18.4 million due to higher operating expenses.
Revenue by Segment
Forward Guidance
Seer anticipates continued commercial momentum leading into the broad release of the Proteograph Product Suite in early 2022.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...